Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension. Current therapeutic research, clinical and experimental. [Curr Ther Res Clin Exp] Journal article
| Advertise on this site. | ||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension. Current therapeutic research, clinical and experimental. [Curr Ther Res Clin Exp] Journal article
| |||||||||||||||||||||||||||||||